Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Harry B Gristick

Showing results (21-30 of 37) with videos related to

Pageof 4
Sort By:
Journal of Virology|September 6, 2024
Short CDRL1 in intermediate VRC01-like mAbs is not sufficient to overcome key glycan barriers on HIV-1 EnvParul Agrawal, Maria L Knudsen, Anna MacCamy, et al.
Nature|October 12, 2020
SARS-CoV-2 neutralizing antibody structures inform therapeutic strategiesChristopher O Barnes, Claudia A Jette, Morgan E Abernathy, et al.
Elife|October 21, 2020
A broadly neutralizing macaque monoclonal antibody against the HIV-1 V3-Glycan patchZijun Wang, Christopher O Barnes, Rajeev Gautam, et al.
Cell|July 10, 2020
Structures of Human Antibodies Bound to SARS-CoV-2 Spike Reveal Common Epitopes and Recurrent Features of AntibodiesChristopher O Barnes, Anthony P West, Kathryn E Huey-Tubman, et al.
Biorxiv : the Preprint Server for Biology|June 25, 2020
Structures of human antibodies bound to SARS-CoV-2 spike reveal common epitopes and recurrent features of antibodiesChristopher O Barnes, Anthony P West, Kathryn E Huey-Tubman, et al.
Cell|February 1, 2020
Restriction of HIV-1 Escape by a Highly Broad and Potent Neutralizing AntibodyPhilipp Schommers, Henning Gruell, Morgan E Abernathy, et al.
Science Translational Medicine|January 20, 2017
Coexistence of potent HIV-1 broadly neutralizing antibodies and antibody-sensitive viruses in a viremic controllerNatalia T Freund, Haoqing Wang, Louise Scharf, et al.
Science Translational Medicine|November 24, 2021
Sequential immunization of macaques elicits heterologous neutralizing antibodies targeting the V3-glycan patch of HIV-1 EnvAmelia Escolano, Harry B Gristick, Rajeev Gautam, et al.
Nature|May 31, 2019
Immunization expands B cells specific to HIV-1 V3 glycan in mice and macaquesAmelia Escolano, Harry B Gristick, Morgan E Abernathy, et al.
Science Immunology|February 10, 2023
CD4 binding site immunogens elicit heterologous anti-HIV-1 neutralizing antibodies in transgenic and wild-type animalsHarry B Gristick, Harald Hartweger, Maximilian Loewe, et al.
Pageof 4

Showing results (21-30 of 37) with videos related to

Sort By:
Pageof 4
Journal of Virology|September 6, 2024
Short CDRL1 in intermediate VRC01-like mAbs is not sufficient to overcome key glycan barriers on HIV-1 EnvParul Agrawal, Maria L Knudsen, Anna MacCamy, et al.
Nature|October 12, 2020
SARS-CoV-2 neutralizing antibody structures inform therapeutic strategiesChristopher O Barnes, Claudia A Jette, Morgan E Abernathy, et al.
Elife|October 21, 2020
A broadly neutralizing macaque monoclonal antibody against the HIV-1 V3-Glycan patchZijun Wang, Christopher O Barnes, Rajeev Gautam, et al.
Cell|July 10, 2020
Structures of Human Antibodies Bound to SARS-CoV-2 Spike Reveal Common Epitopes and Recurrent Features of AntibodiesChristopher O Barnes, Anthony P West, Kathryn E Huey-Tubman, et al.
Biorxiv : the Preprint Server for Biology|June 25, 2020
Structures of human antibodies bound to SARS-CoV-2 spike reveal common epitopes and recurrent features of antibodiesChristopher O Barnes, Anthony P West, Kathryn E Huey-Tubman, et al.
Cell|February 1, 2020
Restriction of HIV-1 Escape by a Highly Broad and Potent Neutralizing AntibodyPhilipp Schommers, Henning Gruell, Morgan E Abernathy, et al.
Science Translational Medicine|January 20, 2017
Coexistence of potent HIV-1 broadly neutralizing antibodies and antibody-sensitive viruses in a viremic controllerNatalia T Freund, Haoqing Wang, Louise Scharf, et al.
Science Translational Medicine|November 24, 2021
Sequential immunization of macaques elicits heterologous neutralizing antibodies targeting the V3-glycan patch of HIV-1 EnvAmelia Escolano, Harry B Gristick, Rajeev Gautam, et al.
Nature|May 31, 2019
Immunization expands B cells specific to HIV-1 V3 glycan in mice and macaquesAmelia Escolano, Harry B Gristick, Morgan E Abernathy, et al.
Science Immunology|February 10, 2023
CD4 binding site immunogens elicit heterologous anti-HIV-1 neutralizing antibodies in transgenic and wild-type animalsHarry B Gristick, Harald Hartweger, Maximilian Loewe, et al.
Pageof 4